Events

Info session: Chips JU Call for Design Platform
JUL
Thu
11
11:00 - 12:00

This was 1 year ago

Location

Online

Programmes
Digital, Industry & Space Semiconductors

The Chips Joint Undertaking (Chips JU) is organising an online information session on the upcoming Call for the Design Platform of the Chips JU

The aim of this call is to select the coordinating hosting entity for the Design Platform with an estimated EU expenditure of up to EUR 25 million.

The CDP includes two interrelated calls:

  • Call for Expression of Interest for the selection of a Hosting Consortium (CDP-CfEoI),
  • Call for Proposals for coordination of the Design Platform funded under the Digital Europe Programme (DEP). The type of action is Coordination and Support Action (CDP-CSA).

In practice, this means that an applicant consortium will have to submit one application that will include two interrelated proposals, one for each of the above-mentioned calls. Each call will have its specific evaluation criteria. A consortium will only be eligible for funding if its proposal for the two calls passes the necessary thresholds.

For successful applicants, the selection of proposals in the CDP leads to the signature of a hosting agreement and a grant agreement.

This information session will address some details of the call, including topic description and budget.

For more information on the session and the possibility to register, please visit the event website.

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Event calendar

 

Testimonial

image of Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.